Kuala Lumpur, 10th) Russia offers to share vaccine production skills and technologies with Malaysia to help my country become a vaccine producer and reduce dependence on other countries.
At present, Russia is the only country that proposes to produce vaccines in Malaysia, because Russia believes that Malaysia’s strategic geographical location is conducive to becoming a vaccine export base in the region. According to the Malay Mail, the Russian ambassador to Malaysia Latipov said that Russia offers to cooperate with Malaysia and is willing to share vaccine production skills and knowledge, capacity building, technology sharing, and vaccine research and development. The next pandemic is coming. If it strikes, Malaysia can make its own vaccine.
"As far as I know, it only takes two or three hours to get from Malaysia to any Southeast Asian country. That's why we think Malaysia is a good place to have this vaccine because it is easy to export the vaccine." Malaysia has ordered 6 million doses of Sputnik V coronavirus vaccine as part of its vaccine inventory, allowing 80% of the population to be vaccinated by the end of this year.
According to reports, except Singapore, all countries in the region are deeply interested in Satellite 5 The Russian ambassador to Malaysia Latipov said that Russia may be on the cusp of geopolitical change, thanks to the Satellite V, which allows the country to drive alongside other major technological powers.
He said that Satellite 5 was developed by the Gamaleya Institute in Moscow, which will work directly with local players, which will help build trust and speed up progress.
According to official sources in Russia, as of the end of February this year, more than 2 billion vaccine orders have been received. So far, 50 countries have approved their populations to be vaccinated with the Satellite V vaccine.
The Russian Investment and Development Fund is the only global sales agent of the vaccine, and it will oversee export matters. The fund cooperated with Duopharma Biotechnology Company to provide Satellite 5 for Malaysia.
Duopharma issued a statement in January this year, stating that the company signed an agreement with the Russian Investment and Development Fund to purchase and supply 6.4 million doses of Satellite 5 for the Ministry of Health.
The company has also been identified as a partner for local vaccine development capabilities. Its parent company Duopharma (M) Sdn Bhd (DMSB) said it will provide warehouses, logistics, ground support and other services to government hospitals and clinics.
Leonard Aliff, the managing director of Duopharma Group, issued a statement that the latest move of the group is consistent with the national vaccination plan, which is to open up domestic vaccines for a long time and reduce dependence on other countries.
The director of health, Dr. Tan Sri Noshiyama, told the media that the National Pharmaceutical Regulatory Agency (NPRA) has not approved Satellite 5 and the vaccine is still under review. Latipov said that cooperation with Duopharma depends on Satellite 5's approval of the NPRA, and believes that the transaction will become a new "pushing force" for the future trade ties between Russia and Malaysia.
As more and more governments believe that Satellite 5 is safe, the number of orders for Satellite 5 worldwide is currently increasing exponentially.
India is one of the world's largest vaccine producers. The country signed a partnership with the Russian Investment and Development Fund in December last year and will produce 300 million doses of Satellite V this year.
Italy also signed the same partnership with the Russian Investment and Development Fund on March 9, becoming the first EU country to sign a related agreement.
Although EU regulatory agencies have not yet approved the vaccine, the public health agencies of Hungary, the Czech Republic, and Slovenia have announced that the vaccine is safe for public use.
holding power is necessary to win.....here stock market i recommend this stock, the new era of pharmaceutical ohhh yeahhhhh.....in cryptocurrency i recommend bitcoin and a bit bit only eg. litecoin and XRP... coz thats the future....
When the price dropped from 3.80 to 3.50, some people alerted the price is going down to 2.00 and we laughed at them....who has the last laugh? Joke is on us to be holding in high valuation. Here we are after -1.00 and at 2.60, hoping for a big break again....second joke.
Leonard is all talk but no action. It would take much more than words to get positive results. Academician are never businessmen. And politicians' words taken with a truck of salt.
@Trevor777...Thank you for your support Keyman188 prospective on the counter...
Keyman188 already highlighted so many time since Dec'20 until Jan'21...
Seem like a lot of newbies felt Keyman188 talk cock or "blow water never wipe mouth"...
You all had seen Jan'21 comments ???...
So what is the price range now ???
Is it almost matching with Keyman188 prediction???...
Keyman188 once again to highlight, if upcoming quarterly result unable to growth further, very high possibility anytime shall be neutralised between 1.80 ~ 2.00....
Please spend some time to review past 2 quarterly report...
Keyman188 still casualty to review this company but Keyman188 will not invest 1st either upcoming quarterly result can indicate further growth or until the share price to be neutralised...
Posted by Keyman188 > Jan 1, 2021 9:08 PM | Report Abuse
Keyman188 always like to repeat & repeat to remind market again...
Time to wake up switching to economy recovery stocks...
Smart money already gone & had switched to others....
Keyman188 foresee further downside risk towards 2.80 ~ 3.00......
If unable to support, further downside risk towards 2.55 ~ 2.65...
Don't be hero to fight current level......
Even though you all plan to keep it for long term...
But not at this point since overall this counter sentiment remained very very weak...
Don't burnt your hard earned money......
For more safety margin better be more patience until below 3.00 then decide again......
Fyi, for the past few years record range, 1.30 ~ 1.60.....
Only this year is different because of heading more speculation then shot up above 4.00......
Posted by Keyman188 > Dec 15, 2020 2:20 PM | Report Abuse
Keyman188 wants to see if the share price drop back to the range 2.00 ~ 2.30 for the next 12 month...then ding dong ding dong this range another 2 /3 years....
that's why...UCrest is pleased to announce that the Company has on 9 April 2021, entered into a MOU with RDIF for management of manufacturing of Sputnik V
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Stockrocket
11 posts
Posted by Stockrocket > 2021-03-10 09:51 | Report Abuse
https://www.nytimes.com/2021/02/05/opinion/covid-vaccines-china-russia.html